Oncology - European Medical Journal

Continue

Oncology

Filter
6 Sep 2016

ESMO Rewards Outstanding Oncologists

Switzerland, September 6, 2016 – The European Society for Medical Oncology (ESMO), the leading professional organisation for medical oncology, has…
16 Aug 2016

Introducing EMJ Reproductive Health 2.1

United Kingdom, August 16, 2016: Welcome to this year’s EMJ Reproductive Health, a journal exploring the latest insights and important developments from…
22 Jul 2016

ESMO 2018 Annual Congress to be held in Munich

Switzerland, 21 July, 2016 – ESMO, the leading European professional organisation for medical oncology, has announced that the ESMO 2018 Annual Congress…
12 Jul 2016

Introducing EMJ Neurology 4.1

Welcome to EMJ Neurology 4.1, an edition filled with informative and engaging content which spotlights the latest research and developments in the field…
5 Jul 2016

Anti-Interleukin-1 Alpha Antibody MABp1 Improves Outcomes Significantly over Placebo

Barcelona-Lugano, July 02, 2016 – A novel anti-interleukin 1-alpha antibody has shown a significant impact on symptoms, and a high level of safety and…
30 Jun 2016

Regorafenib Shows Significant Survival Gains in Refractory Liver Cancer

Barcelona-Lugano, June 30, 2016 – Oral multikinase inhibitor regorafenib achieves significantly improved survival rates compared to placebo in patients…
29 Jun 2016

Anti-PD-L1 Immunotherapy Shows Response in Microsatellite-Stable Metastatic Colorectal Cancer in Combination with MEK Inhibition

June 29, 2016 – Anti-PD-L1 immunotherapy may achieve a response in patients with microsatellite-stable metastatic colorectal cancer if combined with…
13 Jun 2016

Daratumumab (DARZALEX®) Combination Therapy Significantly Extended Progression-Free Survival in Previously Treated Patients with Multiple Myeloma

Beerse, Belgium, 5 June 2016 – Data from the Phase 3 MMY3004 (CASTOR) clinical trial show the immunotherapy daratumumab (DARZALEX®) in combination with a…
We’ve noticed you’re accessing
from North/South America.